KDR-2-2

未知生产厂商

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Antibodies to VEGF-C
US 7423125 B2申请人: VEGENICS LTD优先权: 2004
US
13 件公开
HUMAN ANTI-VEGFR-2/KDR ANTIBODIES
- EP 3204423 A4
  申请人: KADMON CORP LLC优先权: 2014
  CN
  EP
  US
  WO
  9 件公开
- US 10023640 B2
  申请人: KADMON CORP LLC优先权: 2012
  CN
  US
  5 件公开
Modifications of the VEGF Receptor-2 Protein and methods of use
US 6784285 B1申请人: AGOURON PHARMA优先权: 2000
US
7 件公开
COMBINATION OF ANGIOPOIETIN-2 ANTAGONIST AND OF VEGF-A, KDR AND/OR FLTL ANTAGONIST FOR TREATING CANCER
EP 3168234 A1申请人: MEDIMMUNE LTD优先权: 2005
CN
EP
US
6 件公开
Chimeric human-type vascular endothelial cell growth factor
US 7405278 B2申请人: SHIBUYA MASABUMI优先权: 2000
US
4 件公开
DNA vaccine against proliferating endothelial cells and methods of use thereof
US 7094410 B2申请人: SCRIPPS RESEARCH INST优先权: 2002
US
4 件公开
TIMP3 as VEGF inhibitor
US 7183256 B2申请人: CLEVELAND CLINIC FOUNDATION优先权: 2004
US
4 件公开
5-substituted indazoles as kinase inhibitors
US 8648069 B2申请人: AKRITOPOULOU-ZANZE IRINI优先权: 2008
US
4 件公开
Methods and compositions as protein kinase inhibitors
US 7189729 B2申请人: IRM LLC优先权: 2003
CN
US
3 件公开
Compounds and compositions as protein kinase inhibitors
US 7846923 B2申请人: IRM LLC优先权: 2007
CN
US
3 件公开